Pifithrin-α Enhances the Survival of Transplanted Neural Stem Cells in Stroke Rats by Inhibiting p53 Nuclear Translocation

CNS Neuroscience and Therapeutics

Volumn 19, Issue 2, 2013, Pages 109-116

  Lei, Xu Hui ^a   Zhao, Dan ^b   Li, Yong Li ^a   Li, Xian Feng ^a   Sun, Xu ^a   Du, Wen Zhong ^a   Sun, Ying ^a   Hao, Zhong Fei ^a   Xin, Shi Yue ^b   Liu, Cong ^b   Zhang, Zhi Ren ^b   Jiang, Chuan Lu ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell survival; Cell transplantation; P53; Stem cells

Indexed keywords

PIFITHRIN ALPHA; PROTEIN P53; PUMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL COUNT; CELL NUCLEUS; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOPLASM; IMMUNOHISTOCHEMISTRY; MALE; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; UPREGULATION;

ANIMALS; BENZOTHIAZOLES; CELL NUCLEUS; CELL SURVIVAL; CELLS, CULTURED; COMBINED MODALITY THERAPY; MALE; NEURAL STEM CELLS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; STROKE; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84872681231     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12045     Document Type: Article

References (43)

1. Meairs S, Wahlgren N, Dirnagl U, et al. Stroke research priorities for the next decade - a representative view of the European scientific community. Cerebrovasc Dis 2006;22:75-82.
2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
3. Dasgupta B, Gutmann DH. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. J Neurosci 2005;25:5584-5594.
4. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006;441:1094-1096.
5. Bliss T, Guzman R, Daadi M, Steinberg GK. Cell transplantation therapy for stroke. Stroke 2007;38:817-826.
6. Liu YP, Lang BT, Baskaya MK, Dempsey RJ, Vemuganti R. The potential of neural stem cells to repair stroke-induced brain damage. Acta Neuropathol 2009;117:469-480.
7. Bjugstad KB, Teng YD, Redmond DE Jr, et al. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Exp Neurol 2008;211:362-369.
8. Darsalia V, Allison SJ, Cusulin C, et al. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab 2011;31:235-242.
9. Brundin P, Karlsson J, Emgard M, et al. Improving the survival of grafted dopaminergic neurons: A review over current approaches. Cell Transplant 2000;9:179-195.
10. Kelly S, Bliss TM, Shah AK, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci USA 2004;101:11839-11844.
11. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 2005;102:18171-18176.
12. Darsalia V, Kallur T, Kokaia Z. Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum. Eur J Neurosci 2007;26:605-614.
13. Brazel CY, Rosti RT III, Boyce S, Rothstein RP, Levison SW. Perinatal hypoxia/ischemia damages and depletes progenitors from the mouse subventricular zone. Dev Neurosci 2004;26:266-274.
14. Yang Z, Levison SW. Hypoxia/ischemia expands the regenerative capacity of progenitors in the perinatal subventricular zone. Neuroscience 2006;139:555-564.
15. Morrison RS, Kinoshita Y, Johnson MD, Guo W, Garden GA. p53-dependent cell death signaling in neurons. Neurochem Res 2003;28:15-27.
16. Leker RR, Aharonowiz M, Greig NH, Ovadia H. The role of p53-induced apoptosis in cerebral ischemia: Effects of the p53 inhibitor pifithrin alpha. Exp Neurol 2004;187:478-486.
17. Medrano S, Scrable H. Maintaining appearances-the role of p53 in adult neurogenesis. Biochem Biophys Res Commun 2005;331:828-833.
18. Meletis K, Wirta V, Hede SM, Nister M, Lundeberg J, Frisen J. p53 suppresses the self-renewal of adult neural stem cells. Development 2006;133:363-369.
19. Hede SM, Nazarenko I, Nister M, Lindstrom MS. Novel perspectives on p53 function in neural stem cells and brain tumors. J Oncol 2011;2011:852970.
20. Lin T, Chao C, Saito S, et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005;7:165-171.
21. Medrano S, Burns-Cusato M, Atienza MB, Rahimi D, Scrable H. Regenerative capacity of neural precursors in the adult mammalian brain is under the control of p53. Neurobiol Aging 2009;30:483-497.
22. Luo Y, Kuo CC, Shen H, et al. Delayed treatment with a p53 inhibitor enhances recovery in stroke brain. Ann Neurol 2009;65:520-530.
23. Rietze RL, Reynolds BA. Neural stem cell isolation and characterization. Methods Enzymol 2006;419:3-23.
24. Chojnacki A, Weiss S. Production of neurons, astrocytes and oligodendrocytes from mammalian CNS stem cells. Nat Protoc 2008;3:935-940.
25. Suzuki M, Nelson AD, Eickstaedt JB, Wallace K, Wright LS, Svendsen CN. Glutamate enhances proliferation and neurogenesis in human neural progenitor cell cultures derived from the fetal cortex. Eur J Neurosci 2006;24:645-653.
26. Chen X, Tian Y, Yao L, Zhang J, Liu Y. Hypoxia stimulates proliferation of rat neural stem cells with influence on the expression of cyclin D1 and c-Jun N-terminal protein kinase signaling pathway in vitro. Neuroscience 2010;165:705-714.
27. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: Reproducible extensive cortical infarction. Stroke 1986;17:738-743.
28. Kokaia Z, Zhao Q, Kokaia M, et al. Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Exp Neurol 1995;136:73-88.
29. Chen J, Sanberg PR, Li Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001;32:2682-2688.
30. Wohnsland S, Burgers HF, Kuschinsky W, Maurer MH. Neurons and neuronal stem cells survive in glucose-free lactate and in high glucose cell culture medium during normoxia and anoxia. Neurochem Res 2010;35:1635-1642.
31. Culmsee C, Siewe J, Junker V, et al. Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J Neurosci 2003;23:8586-8595.
32. Gil-Perotin S, Marin-Husstege M, Li J, et al. Loss of p53 induces changes in the behavior of subventricular zone cells: Implication for the genesis of glial tumors. J Neurosci 2006;26:1107-1116.
33. Yau TM, Kim C, Ng D, et al. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann Thorac Surg 2005;80:1779-1786.
34. Lee HJ, Kim MK, Kim HJ, Kim SU. Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model. PLoS ONE 2009;4:e5586.
35. Francis KR, Wei L. Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning. Cell Death Dis 2010;1:e22.
36. Jin K, Mao X, Xie L, et al. Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J Cereb Blood Flow Metab 2010;30:534-544.
37. Culmsee C, Zhu X, Yu QS, et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem 2001;77:220-228.
38. Sortwell CE, Pitzer MR, Collier TJ. Time course of apoptotic cell death within mesencephalic cell suspension grafts: Implications for improving grafted dopamine neuron survival. Exp Neurol 2000;165:268-277.
39. Chen J, Chopp M. Neurorestorative treatment of stroke: Cell and pharmacological approaches. NeuroRx 2006;3:466-473.
40. Yonekura I, Takai K, Asai A, Kawahara N, Kirino T. p53 potentiates hippocampal neuronal death caused by global ischemia. J Cereb Blood Flow Metab 2006;26:1332-1340.
41. Jeffers JR, Parganas E, Lee Y, et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003;4:321-328.
42. Cregan SP, Arbour NA, Maclaurin JG, et al. p53 activation domain 1 is essential for PUMA upregulation and p53-mediated neuronal cell death. J Neurosci 2004;24:10003-10012.
43. Toth A, Jeffers JR, Nickson P, et al. Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2006;291:H52-H60.